Notably, the deficiency of PD-L1 in TECs compromised their ability to suppress and induce apoptosis in tumor-infiltrating CD8+ T cells, ultimately leading to the inhibition of tumor development in an in vivo model [95]. The gene discussed is CD8A; the disease is neoplasm.